Evidence map›Paper›PMID 40574750›Full record

ArticleVirus evolution2025

Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya.

Sebastian Musundi, Mike Mwanga, Arnold Lambisia, John M Morobe, Nickson Murunga, Edidah Moraa, Leonard Ndwiga, Robinson Cheruiyot, Jennifer Musyoki, Martin Mutunga and 9 more

Abstract read
In one paragraph

Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sebastian MusundiDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.ORCID https://orcid.org/0000-0003-2940-5717
Mike MwangaDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Arnold LambisiaDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.ORCID https://orcid.org/0000-0001-5312-0960
John M MorobeDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.ORCID https://orcid.org/0000-0003-2398-6717
Nickson MurungaDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Edidah MoraaDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Leonard NdwigaDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Robinson CheruiyotDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Jennifer MusyokiDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Martin MutungaDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Laura M Guzman-RinconDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Charles SandeDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Joseph MwangangiDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Philip BejonDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Lynette Isabella Ochola-OyierDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
David James NokesDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.ORCID https://orcid.org/0000-0001-5426-1984
Charles N AgotiDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.ORCID https://orcid.org/0000-0002-2160-567X
Joyce NyiroDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
George GithinjiDepartment of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.ORCID https://orcid.org/0000-0001-9640-7371

Funding

Wellcome Trust
6 · The paper itself

Abstract

The recombinant FY.4 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant was first reported in Kenya in March 2023 and was the dominant circulating variant between April and July 2023. The variant was characterized by two important mutations: Y451H in the receptor-binding domain of the spike protein and P42L in open reading frame 3a. Using phylogenetics and phylodynamic approaches, we investigated the emergence and spread of FY.4 in Kenya and the rest of the world. Our findings suggest FY.4 circulated early in Kenya before its export to North America and Europe. Early circulation of FY.4 in Kenya was predominantly observed in the coastal part of the country, and the estimated time to the most recent common ancestor suggests FY.4 circulated as early as December 2022. The collected genomic and epidemiological data show that the FY.4 variant led to a large local outbreak in Kenya and resulted in localized outbreaks in Europe, North America, and Asia-Pacific. These findings underscore the importance of sustained genomic surveillance, especially in under-sampled regions, in deepening our understanding of the evolution and spread of SARS-CoV-2 variants.

Indexed as

FY.4KenyaOmicronphylogenetics

Identifiers

PMID40574750
PMCPMC12202047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.